New Ebola Vaccine Cleared For Clinical Trial In Switzerland

The Swiss agency that regulates new drugs says it has approved an application for a clinical trial with an experimental Ebola vaccine at the Lausanne University Hospital.

The trial will be conducted among 120 volunteer participants with support from the U-N World Health Organization. The experimental vaccine is to be initially administered on healthy volunteers who will be sent as medical staff to fight the Ebola epidemic in West Africa. The trial continues a series that began in the United States, Britain and Mali.

The Lausanne trial, which has the backing of the World Health Organization, comes as health authorities around the world grow increasingly alarmed about the outbreak, which has claimed nearly 5,000 lives in eight countries.

ABC’s Tom Rivers joined us to discuss.

Follow us on Twitter: